Herbas VPB

Print
EN | LT
LT - Steroidas su 19-nor C3,3-dipakeistuoju C21-N-pirazolilu, skirtas naudoti terapijoje
EN - 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07J 43/00 (2006.01)
A61K 31/57 (2006.01)
A61K 31/573 (2006.01)
A61K 31/58 (2006.01)
A61P 25/00 (2006.01)
C07J 3/00 (2006.01)
C07J 7/00 (2006.01)
C07J 15/00 (2006.01)
C07J 1/00 (2006.01)
C07J 5/00 (2006.01)
C07J 13/00 (2006.01)
C07J 21/00 (2006.01)
C07J 31/00 (2006.01)
European patent
(11) Number of the document 3498725
(13) Kind of document T
(96) European patent application number 18203320.9
Date of filing the European patent application 2014-04-17
(97) Date of publication of the European application 2019-06-19
(45) Date of publication and mention of the grant of the patent 2021-06-09
(46) Date of publication of the claims translation 2021-09-27
Priority applications
(30) Number Date Country code
PCT/CN2013/074323 2013-04-17 WO
Inventors
(72)
BOTELLA, Gabriel Martinez , US
HARRISON, Boyd, L. , US
ROBICHAUD, Albert, Jean , US
SALITURO, Francesco G. , US
BERESIS, Richard Thomas , CN
Grantee
(73) Sage Therapeutics, Inc. , 215 First Street, Cambridge, MA 02142, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Steroidas su 19-nor C3,3-dipakeistuoju C21-N-pirazolilu, skirtas naudoti terapijoje
  19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY
Last renewal fee
Payment date Validity (years) Amount
2025-03-18 12 289.00 EUR
Next renewal fee
2026-04-17